WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018054953) NANOPARTICULATE PRODRUGS
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/054953    International Application No.:    PCT/EP2017/073740
Publication Date: 29.03.2018 International Filing Date: 20.09.2017
IPC:
A61K 9/51 (2006.01), A61K 31/573 (2006.01)
Applicants: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE [FR/FR]; 3 rue Michel-Ange 75016 Paris (FR).
UNIVERSITÉ PARIS-SUD 11 [FR/FR]; 15 rue Georges Clémenceau 91400 Orsay (FR)
Inventors: FATTAL, Elias; (FR).
TSAPIS, Nicolas; (FR).
LORSCHEIDER, Mathilde; (FR).
CANIONI, Romain; (FR).
REYNAUD, Franceline; (BR)
Agent: CABINET LAVOIX; 2 Place d'Estienne d'Orves 75441 Paris Cedex 09 (FR)
Priority Data:
16189635.2 20.09.2016 EP
Title (EN) NANOPARTICULATE PRODRUGS
(FR) PROMÉDICAMENTS NANOPARTICULAIRES
Abstract: front page image
(EN)The present invention relates to anti-inflammatory drug formulation. Especially, this invention relates to corticosteroid prodrug nanoparticle. In a first aspect, this invention relates to a nanoparticle comprising a therapeutic agent and a surface coating material. The invention also relates to a process of manufacturing at least one nanoparticle of invention. The invention also relates to pharmaceutical composition and pharmaceutical kits.
(FR)La présente invention concerne une formulation de médicament anti-inflammatoire. En particulier, cette invention concerne une nanoparticule de promédicament de corticostéroïdes. Dans un premier aspect, la présente invention concerne une nanoparticule comprenant un agent thérapeutique et un matériau de revêtement de surface. L'invention concerne également un procédé de fabrication d'au moins une nanoparticule de l'invention. L'invention concerne également une composition pharmaceutique et des kits pharmaceutiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)